Tuesday, June 23, 2020 1:33:19 PM
im a fan of a company making money by producing and selling a product...you know, like being successful?...
you know what im against?...a company funding itself on nothing but dilution for 11 years...and then when they are dead broke, the ceo sells his personal shares, loaning the money to the company so it can be in debt to him, and only him...and then he decides that right about then is a good time to dump a couple hundred million shares, r/s and maybe even jump onto Nasdaq...I guess because things are going so well?...
"Complain about dilution before revenues"
11 years of dilution before revenues and then when dead broke, try to dump a couple hundred million shares in one fell swoop....BEFORE REVENUES...
yea...cant imagine why anyone would be worried...what could go wrong?...
I guess if you are not in favor of kblb doing that, you must just want to see all companys go bankrupt...lol
if one has to go to such extremes to make a situation appear palatable, theres definitely something wrong...
"They end up talking down dilution AND companies no longer being going concerns."
as if theres no other earthly way of a company doing anything without diluting the crap out of shareholders...seriously?..
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM